person

Maren H.

Country
Germany
Department
1602:Klinik für Augenheilkunde

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
13
Sites with multiple studies

Has run more than one trial at 13 of 31 partner sites.

Specializations

Endocrine Ophthalmology

The investigator specializes in the treatment and research of Thyroid Eye Disease (TED), focusing on innovative therapeutic approaches for managing this complex autoimmune condition affecting the eyes and surrounding tissues.

  • Orbital Inflammatory Disorders
  • Autoimmune Eye Conditions
  • Advanced Therapeutic Development

Particular emphasis is placed on evaluating novel biological therapies for active TED cases, investigating treatment efficacy and patient tolerability through subcutaneous administration methods.

Clinical Immunology

Research interests extend to the immunological aspects of orbital inflammatory conditions, with a focus on developing targeted therapeutic interventions for autoimmune orbital disorders.

  • Immunological Response Assessment
  • Biological Treatment Modalities
  • Patient Safety Monitoring

The investigator examines immune system responses in ocular conditions, particularly focusing on safety and tolerability profiles of new therapeutic agents.

Therapeutic Innovation

Expertise in evaluating novel treatment administration methods for orbital conditions, with particular attention to optimizing dosing schedules and delivery systems for maximum therapeutic benefit.

  • Drug Delivery Systems
  • Treatment Optimization
  • Clinical Efficacy Assessment

The investigator explores various treatment intervals and administration routes to enhance therapeutic outcomes in orbital inflammatory conditions.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.